Open Access

Sodium sulphate ameliorates hypercholesterolemia via the upregulation of Cyp7a1 in hepatocytes and alleviates hepatic insulin resistance via the downregulation of Trib3 in mice with high cholesterol diets

  • Authors:
    • Yanhong Yang
    • Siping Yu
    • Hedong Rong
    • Zili Lei
    • Changyuan Yang
    • Huijuan Wu
    • Tianle Zhang
    • Fei Yang
    • Ya Nie
    • Lei Chen
    • Qing Hu
    • Qi Song
    • Jiao Guo
  • View Affiliations

  • Published online on: July 12, 2024     https://doi.org/10.3892/etm.2024.12650
  • Article Number: 361
  • Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Amelioration of hypercholesterolemia is essential for the treatment of atherosclerotic cardiovascular disease. Sodium sulphate is the effective component of mirabilite, which has been used in traditional Chinese medicine for the treatment of various diseases. In the present study, C57BL/6 mice were fed with a high‑cholesterol diet (HCD) for 7 weeks and were treated with sodium sulphate in the last three of those weeks. Sodium sulphate significantly reduced the total cholesterol level and the low‑density lipoprotein cholesterol/high‑density lipoprotein cholesterol ratio in the serum of mice fed the HCD. In addition, cytochrome P450 7a1 and 39a1 were significantly upregulated in the livers of mice treated with sodium sulphate. Furthermore, tribbles pseudokinase 3 expression was significantly increased in the livers of mice fed the HCD, but was significantly reduced by sodium sulphate treatment. In terms of the insulin signaling pathway, the ratio of phosphorylated AKT to total AKT in the livers of mice fed the HCD was significantly lower compared with that of control mice fed a normal diet, but was significantly increased by sodium sulphate treatment. Sodium sulphate treatment also reduced the levels of fibroblast growth factor (FGF)15 in the ileum and inhibited the FGF15/FGF receptor 4‑Klotho β/c‑Jun N‑terminal kinase/c‑Jun signaling pathway in the livers of mice fed the HCD. In addition, sodium sulphate changed the composition of the gut microbiota of mice fed the HCD. In conclusion, sodium sulphate may mitigate hypercholesterolemia and hepatic insulin resistance in mice fed an HCD.
View Figures
View References

Related Articles

Journal Cover

September-2024
Volume 28 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yang Y, Yu S, Rong H, Lei Z, Yang C, Wu H, Zhang T, Yang F, Nie Y, Chen L, Chen L, et al: Sodium sulphate ameliorates hypercholesterolemia via the upregulation of <em>Cyp7a1</em> in hepatocytes and alleviates hepatic insulin resistance via the downregulation of <em>Trib3</em> in mice with high cholesterol diets. Exp Ther Med 28: 361, 2024.
APA
Yang, Y., Yu, S., Rong, H., Lei, Z., Yang, C., Wu, H. ... Guo, J. (2024). Sodium sulphate ameliorates hypercholesterolemia via the upregulation of <em>Cyp7a1</em> in hepatocytes and alleviates hepatic insulin resistance via the downregulation of <em>Trib3</em> in mice with high cholesterol diets. Experimental and Therapeutic Medicine, 28, 361. https://doi.org/10.3892/etm.2024.12650
MLA
Yang, Y., Yu, S., Rong, H., Lei, Z., Yang, C., Wu, H., Zhang, T., Yang, F., Nie, Y., Chen, L., Hu, Q., Song, Q., Guo, J."Sodium sulphate ameliorates hypercholesterolemia via the upregulation of <em>Cyp7a1</em> in hepatocytes and alleviates hepatic insulin resistance via the downregulation of <em>Trib3</em> in mice with high cholesterol diets". Experimental and Therapeutic Medicine 28.3 (2024): 361.
Chicago
Yang, Y., Yu, S., Rong, H., Lei, Z., Yang, C., Wu, H., Zhang, T., Yang, F., Nie, Y., Chen, L., Hu, Q., Song, Q., Guo, J."Sodium sulphate ameliorates hypercholesterolemia via the upregulation of <em>Cyp7a1</em> in hepatocytes and alleviates hepatic insulin resistance via the downregulation of <em>Trib3</em> in mice with high cholesterol diets". Experimental and Therapeutic Medicine 28, no. 3 (2024): 361. https://doi.org/10.3892/etm.2024.12650